Abstract

Background: Rheumatoid arthritis (RA) was a prevalent chronic inflammatory illness that can cause partial hearing loss. Due to that, our study was conducted a comparative study that assess hearing impairment for patients and control groups. Patients and methods: Clinical outcomes were performed into patients who having hearing impairments, where it included 80 participants, which divided into two groups. Group A represented the patients’ group, where participants with rheumatoid arthritis (40), and Group B, shown control group, who participants without rheumatoid arthritis (40). We were measuring hearing thresholds with ultra-high-frequency audiometry in both groups, the patients’ group and the control group. Also, tympanometry, pure speech audiometry, along with otoacoustic emission measurements were all accomplished. Results: Clinical outcomes of hearing loss evaluation, we found atients with ages (61 – 70) years were higher with 32 cases, males were lower with 45% than females with 55%, obesity with 32 cases, rate of smokers 35%, family history of hearing loss was 30%, medications that are ototoxic was 25%, previous surgery was 60%, hypertension included 64 cases, diabetes included 32 cases, diabetes included 32 cases, chronic Kidney disease included 24 cases, symptoms found tinnitus have 11 cases, conductive hearing loss have 6 cases, and sensorineural hearing loss have 5 cases in the patient’s group, and seven while tinnitus have 7 cases, conductive hearing loss have 8 cases, and sensorineural hearing loss have 9 cases in the control group. According to the hearing threshold with ultra-high-frequency audiometry, we noticed hearing started at 29.08 HZ at an intensity (8000) dB in the patients’ group, while the frequency was 11.86 HZ at the intensity of 8000 and end up at a frequency of 40.49 HZ at 17938.95 intensity in the control group. Conclusion: Our recent investigation found that patients with rheumatoid arthritis had greater hearing impairment than the control group